Health Care/Hospital
BEYOND Expo 2022 Early Bird Booth Registration - Ending August 31st
MACAU, Aug. 8, 2022 /PRNewswire/ -- The BEYOND Expo Organizing Committee has officially released the details for BEYOND Expo 2022. Due to COVID-19 restrictions, it will be held virtually fromSeptember 21st-27th in the metaverse. The conference will host exclusive summits on investment and web3, ...
2022-08-08 13:05
4635
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development
BEIJING, Aug. 8, 2022 /PRNewswire/ -- The 2022 Taihu Bay Future Healthcare Conference held Thursday in Wuxi City in eastChina's Jiangsu Province witnessed the launch of Wuxi Intellectual Property Protection Center with 52 biomedical projects contracted, involving a total of more than30 billion yu...
2022-08-08 12:24
2357
Qmed Asia launches Qmed GO "Mini Clinics" to Solve Rising Employee Healthcare Costs
Disrupting the medical landscape through an innovative internet-enabled
clinical kiosk.
KUALA LUMPUR, Malaysia, Aug. 8, 2022 /PRNewswire/ -- Qmed Asia
2022-08-08 10:15
2478
BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition
Exhibition visitors surpass 100,000 people over 4 days BIO Asia–Taiwan success a testament to Taiwan's booming biotechnology industry TAIPEI, Aug. 8, 2022 /PRNewswire/ -- BIO Asia–Taiwan 2022, held at the TaiNEX 2 Exhibition Center, Nangang,Taipei, from 27-31 July, came to a successful conclusio...
2022-08-08 10:00
4878
BioDuro-Sundia and X-Chem enter partnership to launch DEL services in China for the discovery of new small molecule drugs
SHANGHAI, Aug. 8, 2022 /PRNewswire/ -- BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound Library (...
2022-08-08 09:06
2191
Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFNγ in a concentration dependent manner with an EC50 of 2.86 nM. Ma...
2022-08-08 08:10
2121
CStone presents updated results of a registrational study of sugemalimab in patients with stage III NSCLC via oral presentation at WCLC 2022
* GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator ProfessorYi-Long Wu was invited to highlight key data in a press conference * In the final progression-free survival analysis, sugemalimab showed sustained ...
2022-08-08 08:08
2038
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer
SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces the appointment of Dr. ...
2022-08-08 08:00
2157
Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema
SAN FRANCISCO and SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2022-08-08 08:00
2278
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant
MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has been jointly awarded a$4.8 million Australian Research Council (ARC) grant to establish a new Industrial Transformation Research Program (ITRP) Hub as part o...
2022-08-08 07:55
2182
BGI's Global Life Science Research Leadership Recognized in 2022 Nature Index
SHENZHEN, China, Aug. 5, 2022 /PRNewswire/ -- BGI's leading global position in life science research has been recognized in the 2022 Nature Index. BGI rose two places to 8th in the world among corporate institutions for its contribution to life science research and was the only Chinese corporate ...
2022-08-05 22:18
5202
Hisense South Africa Donates an Ultrasound HD60 to The Peninsular Maternity Trust for Mowbray Maternity Hospital
CAPE TOWN, South Africa, Aug. 5, 2022 /PRNewswire/ -- At a donation ceremony on July 28, Hisense, a manufacturer and provider of high-performance electronics and medical devices, delivered a cutting-edge, high-resolution, ultrasound machine, the Hisense Ultrasound HD60, to the Peninsula Maternity...
2022-08-05 15:13
1312
FWD partners with Klook for customers in Southeast Asia
Accident Cover will be available through Klook in one seamless customer journey HONG KONG, Aug. 5, 2022 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "the Company") is delighted to announce a unique distribution partnership with Klook, a leading travel and leisure e-commerce platform...
2022-08-05 10:29
4717
ECOLAB NAMES GREGORY LUKASIK SENIOR VICE PRESIDENT AND MARKET HEAD FOR SOUTHEAST ASIA
SINGAPORE, Aug. 5, 2022 /PRNewswire/ -- Ecolab Inc., the global leader in
water, hygiene and infection prevention solutions and services, namedGregory
Lukasik
2022-08-05 09:00
6874
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
* Collaboration to accelerate the development and access of oncology medicines for cancer patients inChina * Clinical trial programs combining two of Sanofi's prioritized oncology assets with sintilimab, the leading checkpoint inhibitor inChina, to address some of the most prevalent solid tum...
2022-08-04 23:30
3764
MGI Announces Commercial Availability of HotMPS Sequencing Chemistry*and Instrument**in the United Kingdom
SHENZHEN, China, July 28, 2022 /PRNewswire/ -- MGI Tech (MGI) announced that its innovative HotMPS sequencing chemistry* and instrument** are commercially available in theUnited Kingdom, from 23rd June 2022. Further details will be communicated during the 17th Annual Meeting of the International ...
2022-08-04 22:50
2419
Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector
* Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology clinical trials market * Genesis Capital is partnering with existing management to expand ...
2022-08-04 22:01
3080
TCEB and Phuket Welcome Enquiry Mission Members from World Expo's Governing Body to Assess Phuket's Candidacy for Expo 2028
BANGKOK, Aug. 4, 2022 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in partnership withPhuket City and Thailand's Ministry of Public Health, welcomed nine Enquiry Mission Members from Bureau International des Expositions (BIE), the governing body of World Expos, as guests of t...
2022-08-04 19:08
2004
Fullerton Health Completes Merger Led By RRJ Capital; Stronger Balance Sheet and New Corporate Structure Will Propel Post-Pandemic Growth Opportunities
SINGAPORE, Aug. 4, 2022 /PRNewswire/ -- Fullerton Health Corporation Limited ("Fullerton Health" or the "Company") announced today that it has completed a merger led by RRJ Capital ("RRJ") involving an equity injection by the private equity firm and a senior loan totallingS$390 million. The merge...
2022-08-04 13:11
5568
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA
HANGZHOU, China and SHAOXING, China, Aug. 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the Investigational New Drug (IND) application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for COVID-19, has been accep...
2022-08-04 08:10
2406
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
7882
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
7811
Animated Life in Yunnan
2024-04-18 14:00
7781
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
6155
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3865